These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 27612989)
1. Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells. Ullmark T; Järvstråt L; Sandén C; Montano G; Jernmark-Nilsson H; Lilljebjörn H; Lennartsson A; Fioretos T; Drott K; Vidovic K; Nilsson B; Gullberg U Haematologica; 2017 Feb; 102(2):336-345. PubMed ID: 27612989 [TBL] [Abstract][Full Text] [Related]
2. DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses. Ullmark T; Montano G; Gullberg U Eur J Haematol; 2018 Mar; 100(3):229-240. PubMed ID: 29240258 [TBL] [Abstract][Full Text] [Related]
3. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one. Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038 [TBL] [Abstract][Full Text] [Related]
4. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain. Morrison AA; Venables JP; Dellaire G; Ladomery MR Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543 [TBL] [Abstract][Full Text] [Related]
7. The predominant WT1 isoform (+KTS) encodes a DNA-binding protein targeting the planar cell polarity gene Scribble in renal podocytes. Wells J; Rivera MN; Kim WJ; Starbuck K; Haber DA Mol Cancer Res; 2010 Jul; 8(7):975-85. PubMed ID: 20571064 [TBL] [Abstract][Full Text] [Related]
8. RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1. Nishikawa T; Wojciak JM; Dyson HJ; Wright PE Biochemistry; 2020 Oct; 59(40):3889-3901. PubMed ID: 32955251 [TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes. Laity JH; Chung J; Dyson HJ; Wright PE Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004 [TBL] [Abstract][Full Text] [Related]
10. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Han Y; San-Marina S; Yang L; Khoury H; Minden MD Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147 [TBL] [Abstract][Full Text] [Related]
11. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system. Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344 [TBL] [Abstract][Full Text] [Related]
12. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites. Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058 [TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor. Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658 [TBL] [Abstract][Full Text] [Related]
14. Wilms tumor and the WT1 gene. Lee SB; Haber DA Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525 [TBL] [Abstract][Full Text] [Related]
15. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers. Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984 [TBL] [Abstract][Full Text] [Related]
16. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants. Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762 [TBL] [Abstract][Full Text] [Related]
17. A new role for wilms tumor protein 1: differential activities of + KTS and -KTS variants to regulate LHβ transcription. Bagchi D; Andrade J; Shupnik MA PLoS One; 2015; 10(1):e0116825. PubMed ID: 25617744 [TBL] [Abstract][Full Text] [Related]
18. HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms. Li H; Hou S; Hao T; Azam S; Liu C; Shi L; Lei H RNA Biol; 2015; 12(12):1364-71. PubMed ID: 26512748 [TBL] [Abstract][Full Text] [Related]
19. Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs. Lopotová T; Polák J; Schwarz J; Klamová H; Moravcová J Blood Cells Mol Dis; 2012 Jun; 49(1):41-7. PubMed ID: 22555024 [TBL] [Abstract][Full Text] [Related]
20. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo. Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]